Description
Ipamorelin 5 mg research overview
Ipamorelin selective GHRP research peptide for ghrelin receptor and GH signalling studies. COA supplied. RUO.
Ipamorelin is a selective ghrelin receptor agonist used to study growth-hormone release and endocrine signalling.
Peptide Shop supplies Ipamorelin 5 mg as a sealed research material with lot-level documentation where available. This product is supplied for in-vitro laboratory research only and is not intended for human or veterinary diagnostic, therapeutic, cosmetic or consumption purposes.
Research use
- Ghrelin receptor activation studies
- Growth-hormone release models
- Endocrine pathway comparisons with GHRP-2 and GHRP-6
Mapped to hormone and anti-ageing research clusters.
Sequence and analytical data
| Field | Detail |
|---|---|
| Product ID | peptide-ipamorelin |
| Package size | 1 × 5 mg vial |
| CAS number | 170851-70-4 |
| Molecular weight | 711.9 g/mol |
| Purity | ≥ 99% |
| Storage | -20°C recommended (research-only) |
Batch-specific documentation may include HPLC purity, identity confirmation and lot information. Refer to the supplied COA or the COA policy for current documentation scope.
Reconstitution and handling
Allow lyophilised material to equilibrate before opening to reduce condensation risk. Add validated solvent slowly down the vial wall, avoid vigorous shaking, and record the final concentration in the laboratory notebook or LIMS.
Use aseptic technique, calibrated pipettes or syringes, and validated diluent choices for the assay system. Reconstituted materials should be aliquoted where appropriate to reduce repeated freeze-thaw exposure.
Storage
Store unopened material according to the stated condition: -20°C recommended (research-only). Keep vials sealed, dry and protected from light. Reconstituted solutions should be stored under validated laboratory conditions and discarded according to internal SOPs and applicable research-waste rules.
Related resources
Research-use statement
Ipamorelin 5 mg is sold by Peptide Shop for research use only. It is not a medicine, food, cosmetic, supplement or diagnostic product. Buyers are responsible for ensuring lawful purchase, storage, handling and disposal under their institutional and local requirements.
References
- Raun K et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552–561. PMID 9849822
- Bowers CY. “Unnatural Growth Hormone-Releasing Peptide Begets Natural Ghrelin.” J Clin Endocrinol Metab. 2001;86(4):1464–1469. PMID 11297567
- Gobburu JV et al. “Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.” Pharm Res. 1999;16(9):1412–1416. PMID 10496659
- Lall S et al. “Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues.” Biochem Biophys Res Commun. 2001;280(1):132–138. PMID 11162490
